This paper describes the application of activity-based costing (ABC) to cal­ culate unit costs for a healthcare or­ ganization in a developing country. It also describes the ways in which these calculations can provide infor­ mation for improving the efficiency and quality of healthcare services. The study was conducted from June 1, 1997 through May 31, 1998 at the MaxSalud Institute for High Q...

This research based on the formulation and purpose of study tower scenic bakery in probolinggo for analyzing determination base price production a method activity costing. The kind this using quantitative descriptive according to primary data skunder. Variables used it is composed costing price. Production. analysis if from report costs years 2018 which includes data, raw material labor, overhe...

We present the model of a new information system for agribusiness management that supports Direct Costing and Activity Based Costing methodologies. We conducted interviews with key-informants to evaluate their needs and identify the information requirements for the introduction of structured cost management approaches in a Farm Management Information System. The paper presents a viable design o...

Aims: To outline the scope for use of new methods of grouping patient information (HRGs and HBGs) in program budgeting, disease costing and healthcare needs assessment. Methods: Review of methods of costing diseases, setting priorities and of developments in costing and valuing groups of patients/treatments. Results: HRGs, which are shortly to be available in England covering all acute hospital...

www.pharmacypractice.org (ISSN: 1886-3655) 1 ABSTRACT The short-comings of current anticoagulants have led to the development of newer, albeit more expensive, oral alternatives. Objective: To explore the potential impact the new anticoagulants dabigatran and rivaroxaban in the local hospital setting, in terms of utilisation and subsequent costing. Method: A preliminary costing analysis was perf...

UNLABELLED The short-comings of current anticoagulants have led to the development of newer, albeit more expensive, oral alternatives. OBJECTIVE To explore the potential impact the new anticoagulants dabigatran and rivaroxaban in the local hospital setting, in terms of utilisation and subsequent costing. METHOD A preliminary costing analysis was performed based on a prospective 2-week clini...